Longevity and cellular energy

SS-31, MOTS-c, NAD+, epithalon, pinealon. The biggest claims in the market, the thinnest evidence, and the one that became a real medicine.

This is the category with the biggest promises and, with one exception, the thinnest evidence. The exception is a peptide that has now become an approved drug for a rare disease, which is worth understanding because it shows what the others would need to become to earn their reputations. Most of these act on mitochondria, the tiny power plants inside every cell, which slow down as you age.